Nosis Bio
Nosis Bio is enabling the future of targeted drug delivery by integrating deep expertise in generative AI and high-throughput biochemistry.
Why it ranks
How the rank works2signal of 100 · rising 1
- went through AWS GenAIProgram · this site+2
A sum of public facts, not a judgement and not investment advice.
Competitors
| Company | Category | Status | Program |
|---|---|---|---|
| AI | Not stated | Plug and Play | |
| AI | Active | YCW19 | |
| AI | Active | YCS19 | |
| AI | Active | YCW20 | |
| AI | Active | YCW26 |
Adjacent
| Company | Category | Status | Program |
|---|---|---|---|
| Other | Not stated | Antler2025 | |
| Other | Active | YCW18 | |
| Other | Active | YCW19 | |
| Other | Not stated | 500 Global2021 | |
| Other | Active | YCW20 |
Also from AWS GenAI Inaugural cohort in AI
All of AWS GenAI Inaugural cohortPrograms
| Program | Cohort | Source |
|---|---|---|
| Inaugural cohort | AWS GenAI Page |
About Nosis Bio
- Category
- AI
- Checked
- 30h ago
Nosis Bio: questions
Which accelerators did Nosis Bio go through?
Nosis Bio is listed by AWS Generative AI Accelerator (GenAI Inaugural cohort).